Global Radiopharmaceutical/Nuclear Medicine Market Report By Type (Diagnostic Nuclear Medicine And Therapeutic Nuclear Medicine), By Application (Diagnostic Application And Therapeutic Application) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210229
January 2020
Report Formats:
As per this study, the Global Radiopharmaceutical/Nuclear Medicine Market was valued USD 3.87 BN (by revenue) in 2018 and is anticipated to reach USD 5.82 BN by 2025 with a CAGR of 6%.
Radiopharmaceutical/nuclear medicine refers to a radioactive drug used for monitoring and treating patients suffering from cancer, heart related problems, and neural issues. The trace amount of radioisotope present in the medicine binds the organic compound, which is later conveyed, to the target cell, tissue or organ. The rays emitted by radioisotope are detected by specific imaging device. The gamma rays are used for diagnostic purpose whereas short-range alpha or beta rays are used for treatment purpose.
Market Dynamics
Rising commonness of cancer and cardiovascular diseases has led the demand for nuclear medicine. Increasing spending on healthcare followed by rising awareness regarding the medicine is also contributing the market growth. Owing to non-invasive treatment, radiopharmaceutical/nuclear medicine is gaining major traction. However, short-term time of nuclear medicine is likely to hinder the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of radiopharmaceutical/nuclear medicine.
Market Segmentation
The broad radiopharmaceutical/nuclear medicine market has been sub-grouped into type, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- PETRadiopharmaceuticals
- Therapeutic Nuclear Medicine
- Alpha Emitters
- Beta Emitters
- Brachytherapy Isotopes
By Application
- Diagnostic Application
- SPECT Application
- Cardiology
- Lymphoma
- Neurology
- Thyroid
- Other
- PET Application
- Oncology
- Cardiology
- Neurology
- Other
- SPECT Application
- Therapeutic Application
- Thyroid
- Bone Metastasis
- Lymphoma
- Endocrine Tumor
- Other Therapeutic Application
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for radiopharmaceutical/nuclear medicine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Radiopharmaceutical/Nuclear Medicine Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the radiopharmaceutical/nuclear medicine market include Advanced Accelerator Applications, Bayer, Bracco Imaging, Cardinal Health, Curium, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Lantheus Medical Imaging and Nordion among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1. INTRODUCTION
- Introduction To Radiopharmaceutical/Nuclear Medicine
- Report Description
- Objectives Of The Study
- Assumptions
- Research Scope
- Research Methodology
- Data Source
2. EXECUTIVE SUMMARY
- Market Highlight
- Global Radiopharmaceutical/Nuclear Medicine Market: Snapshot
3. MARKET ANALYSIS
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
- Value Chain Analysis
4. RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY TYPE
- Market In Diagnostic Nuclear Medicine
- Market In SPECT Radiopharmaceuticals
- Market In PET Radiopharmaceuticals
- Market In Therapeutic Nuclear Medicine
- Market In Alpha Emitters
- Market In Beta Emitters
- Market In Brachytherapy Isotopes
5. RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY APPLICATION
- Market In Diagnostic Application
- Market In SPECT Application
- Market In Cardiology
- Market In Lymphoma
- Market In Neurology
- Market In Thyroid
- Market In Other
- Market In PET Application
- Market In Oncology
- Market In Cardiology
- Market In Neurology
- Market In Other
- Market In SPECT Application
- Market In Therapeutic Application
- Market In Thyroid
- Market In Bone Metastasis
- Market In Lymphoma
- Market In Endocrine Tumor
- Market In Other Therapeutic Application
6. RADIOPHARMACEUTICAL/NUCLEAR MEDICINE MARKET ANALYSIS BY GEOGRAPHY
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
7. COMPETITIVE LANDSCAPE OF THE RADIOPHARMACEUTICAL/NUCLEAR MEDICINE COMPANIES
- Market Competition
- Partnerships/Collaborations/Agreements
- Mergers And Acquisitions
- New Product Launches
- Other Developments
8. COMPANY PROFILES OF THE RADIOPHARMACEUTICAL/NUCLEAR MEDICINE INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- Advanced Accelerator Applications
- Bayer
- Bracco Imaging
- Cardinal Health
- Curium
- Eczacibasi-Monrol Nuclear Products
- Ge Healthcare
- Lantheus Medical Imaging
- Nordion
* Tentative TOC
LIST OF TABLES
Table 1. Market Highlights Of Radiopharmaceutical/Nuclear Medicine
Table 2. Global Radiopharmaceutical/Nuclear Medicine Market By Type
Table 3. Global Radiopharmaceutical/Nuclear Medicine Market By Application
Table 4. Global Radiopharmaceutical/Nuclear Medicine Market By Geography
Table 5. North America Radiopharmaceutical/Nuclear Medicine Market
Table 6. Europe Radiopharmaceutical/Nuclear Medicine Market
Table 7. Asia Pacific Radiopharmaceutical/Nuclear Medicine Market
Table 8. Latin America Radiopharmaceutical/Nuclear Medicine Market
Table 9. Middle East And Africa Radiopharmaceutical/Nuclear Medicine Market
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Radiopharmaceutical/Nuclear Medicine Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Radiopharmaceutical/Nuclear Medicine
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 7. Global Radiopharmaceutical/Nuclear Medicine Market By Type
Fig. 8. Global Radiopharmaceutical/Nuclear Medicine Market By Application
Fig. 9. Global Radiopharmaceutical/Nuclear Medicine Market By Geography
Fig. 10. North America Radiopharmaceutical/Nuclear Medicine Market
Fig. 11. Europe Radiopharmaceutical/Nuclear Medicine Market
Fig. 12. Asia Pacific Radiopharmaceutical/Nuclear Medicine Market
Fig. 13. Latin America Radiopharmaceutical/Nuclear Medicine Market
Fig. 14. Middle East And Africa Radiopharmaceutical/Nuclear Medicine Market
Fig. 15. Market Share Of Radiopharmaceutical/Nuclear Medicine Companies
Fig. 16. Recent Developments In Radiopharmaceutical/Nuclear Medicine Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
